Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Linseis is a private German manufacturer of thermal analysis, calorimetry, and thermophysical property measurement instruments used in materials research, quality control, and selected life science and pharmaceutical applications. The company develops and sells systems such as differential scanning calorimeters, simultaneous thermal analyzers, dilatometers, thermal conductivity and diffusivity analyzers, and related high-temperature measurement platforms. While Linseis is not a drug developer, it is relevant to healthcare and life sciences through calorimetry and analytical tools used by pharmaceutical, biology, and R&D laboratories. The company was founded in the 1950s in Selb, Germany, has an international presence including the United States, China, and India, and appears to remain independently operated. Its recent majority stake acquisition in Calneos expands its position in biothermal and pharmaceutical calorimetry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Linseis.